Investors Buy Shares of UnitedHealth Group Incorporated (UNH) on Weakness

Traders bought shares of UnitedHealth Group Incorporated (NYSE:UNH) on weakness during trading hours on Monday. $230.31 million flowed into the stock on the tick-up and $83.78 million flowed out of the stock on the tick-down, for a money net flow of $146.53 million into the stock. Of all companies tracked, UnitedHealth Group had the highest net in-flow for the day. UnitedHealth Group traded down ($1.76) for the day and closed at $196.30

UNH has been the topic of a number of research analyst reports. Cowen and Company reissued an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $203.59.

The company’s 50 day moving average is $196.36 and its 200 day moving average is $183.56. The company has a market cap of $189.79 billion, a price-to-earnings ratio of 23.58 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In related news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock valued at $14,981,909 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Osborn Williams & Donohoe LLC lifted its position in shares of UnitedHealth Group by 6.1% during the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock worth $2,743,000 after purchasing an additional 810 shares during the last quarter. Curbstone Financial Management Corp lifted its position in shares of UnitedHealth Group by 74.7% during the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock worth $744,000 after purchasing an additional 1,625 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $1,254,000. Intl Fcstone Inc. acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $2,324,000. Finally, RNC Capital Management LLC lifted its position in shares of UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital

UNH has been the topic of a number of research analyst reports. Cowen and Company reissued an “outperform” rating and issued a $220.00 price target (up from $175.00) on shares of UnitedHealth Group in a research note on Friday, August 11th. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Morgan Stanley raised their price target on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research note on Thursday, August 17th. Jefferies Group LLC reissued a “buy” rating and issued a $215.00 price target on shares of UnitedHealth Group in a research note on Friday, August 18th. Finally, ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday. Three research analysts have rated the stock with a hold rating and twenty-three have assigned a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $203.59.

The company’s 50 day moving average is $196.36 and its 200 day moving average is $183.56. The company has a market cap of $189.79 billion, a price-to-earnings ratio of 23.58 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 18th. The healthcare conglomerate reported $2.46 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.08. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.32%. The company had revenue of $50.05 billion during the quarter, compared to analysts’ expectations of $49.97 billion. During the same quarter in the previous year, the firm earned $1.96 earnings per share. The business’s quarterly revenue was up 7.7% compared to the same quarter last year. Analysts predict that UnitedHealth Group Incorporated will post $9.87 earnings per share for the current year.

The business also recently declared a quarterly dividend, which was paid on Tuesday, September 19th. Shareholders of record on Friday, September 8th were given a $0.75 dividend. The ex-dividend date was Thursday, September 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 35.13%.

In related news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction dated Friday, September 15th. The stock was sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the completion of the transaction, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $199.49, for a total value of $1,117,144.00. Following the transaction, the director now directly owns 60,834 shares of the company’s stock, valued at approximately $12,135,774.66. The disclosure for this sale can be found here. Insiders sold 76,174 shares of company stock valued at $14,981,909 in the last ninety days. Insiders own 0.89% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. Osborn Williams & Donohoe LLC lifted its position in shares of UnitedHealth Group by 6.1% during the 3rd quarter. Osborn Williams & Donohoe LLC now owns 14,006 shares of the healthcare conglomerate’s stock worth $2,743,000 after purchasing an additional 810 shares during the last quarter. Curbstone Financial Management Corp lifted its position in shares of UnitedHealth Group by 74.7% during the 3rd quarter. Curbstone Financial Management Corp now owns 3,800 shares of the healthcare conglomerate’s stock worth $744,000 after purchasing an additional 1,625 shares during the last quarter. MPS Loria Financial Planners LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $1,254,000. Intl Fcstone Inc. acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth about $2,324,000. Finally, RNC Capital Management LLC lifted its position in shares of UnitedHealth Group by 0.7% during the 2nd quarter. RNC Capital Management LLC now owns 1,940 shares of the healthcare conglomerate’s stock worth $360,000 after purchasing an additional 13 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: “Investors Buy Shares of UnitedHealth Group Incorporated (UNH) on Weakness” was first reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://ledgergazette.com/2017/10/09/investors-buy-shares-of-unitedhealth-group-incorporated-unh-on-weakness-2.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply